Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-033133
Filing Date
2022-06-01
Accepted
2022-06-01 16:08:32
Documents
1
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3913
  Complete submission text file 0001209191-22-033133.txt   5526
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O TRIMERIS, INC. 2530 MERIDIAN PARKWAY, 2ND FLOOR DURHAM NC 27713
Business Address
MATTINGLY MARTIN A (Reporting) CIK: 0001265782 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 22987393